Pfizer’s 20-valent Pneumococcal Conjugate Vaccine Now Approved in Malaysia, Protecting Against 20 Pneumococcal Strains
Now approved for use in individuals from 6 weeks to less than 18 years of age, and in adults aged 18 years and above across Malaysia1. Covers 20 disease-causing pneumococcal serotypes, including 7 additional strains
Continue reading